SapC–DOPS as a Novel Therapeutic and Diagnostic Agent for Glioblastoma Therapy and Detection: Alternative to Old Drugs and Agents

Glioblastoma multiforme (GBM), the most common type of brain cancer, is extremely aggressive and has a dreadful prognosis. GBM comprises 60% of adult brain tumors and the 5 year survival rate of GBM patients is only 4.3%. Standard-of-care treatment includes maximal surgical removal of the tumor in c...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaynak, Ahmet, Davis, Harold W., Vallabhapurapu, Subrahmanya D., Pak, Koon Y., Gray, Brian D., Qi, Xiaoyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619974/
https://www.ncbi.nlm.nih.gov/pubmed/34832975
http://dx.doi.org/10.3390/ph14111193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619974/
https://www.ncbi.nlm.nih.gov/pubmed/34832975
http://dx.doi.org/10.3390/ph14111193

Ejemplares similares